Article · Testosterone Therapy

TRT Myths Men Still Believe, Checked Against the Evidence

Short answer

Most TRT myths fall apart against the evidence. The aggression listed on testosterone labels is tied to abuse at high doses, not treatment to normal levels. Benefits arrive over weeks to months, not days. The TRAVERSE trial found no rise in heart attacks or strokes. Therapy aimed at normal levels differs from steroid abuse, yet it still carries real risks that monitoring is designed to catch.

By the Ultimate Male team · Updated October 8, 2026

Smiling older man stretching a resistance band

The short version

Most of what men hear about testosterone therapy is either outdated or borrowed from the world of steroid abuse. When you line the common claims up against trial data and the warnings printed on testosterone labels, the picture is calmer than the rumors and more specific than the marketing.

That does not make treatment risk-light. Each myth below hides a real issue, and each real issue has a lab test or check that keeps an eye on it. Here is the whole argument in one table before the details.

Myth What the evidence shows What monitoring addresses it
Roid rage Aggression is tied to abuse-level doses Levels checked so dosing stays in range
Instant results Effects build over weeks to months Follow-up visits that track symptoms over time
Heart attacks No rise in TRAVERSE, but more arrhythmia and clots Blood pressure, rhythm symptoms, kidney labs
Same as abuse Different dose and goal, same controlled drug Lab-guided dosing and supervised refills
Boosts fertility Can suppress sperm production Fertility plans discussed before starting

Myth 1: “TRT turns you into a rage monster”

This one comes from steroid abuse, not from medical treatment. The Kyzatrex label lists hostility, aggression, mania and psychosis among reactions reported in people who abuse anabolic steroids, typically at doses above those used for treatment and often combined with other steroids. The National Institute on Drug Abuse notes that misuse doses can run 10 to 100 times higher than medical doses, and that the evidence linking steroids to aggression comes mostly from case reports and small studies that may be confounded by personality traits.

Treatment aimed at normal levels looks different in trials. In the large TRAVERSE trial, a mood substudy of 5,204 men found that testosterone brought modest improvements in mood and energy compared with placebo, not deterioration. Some men do notice irritability, usually when levels swing high after an injection, and that is a dosing conversation. Our answer on TRT mood swings and irritability covers it.

Myth 2: “You will feel it within days”

Benefits build over weeks and months, and they arrive on different clocks. A review of the time course of testosterone’s effects pulled together published studies and found this pattern:

Effect When it starts When it levels off
Sexual interest About 3 weeks About 6 weeks
Erections and ejaculation Can take up to 6 months Not specified
Mood 3 to 6 weeks 18 to 30 weeks
Fat mass, lean mass, strength 12 to 16 weeks 6 to 12 months
Red blood cell production Evident at 3 months 9 to 12 months

Men who expect a transformation in the first week often decide treatment failed, or push for a higher dose too soon. The last row matters most for safety: the rise in red blood cells shows up months in, long after the early sense of benefit, which is why hematocrit is rechecked during treatment. Our article on how long TRT takes to work walks through the first year.

Myth 3: “Testosterone causes heart attacks”

The strongest evidence available says it does not raise heart attack or stroke risk in men treated for genuinely low levels. The TRAVERSE trial followed 5,246 men aged 45 to 80 with heart disease or high cardiovascular risk. Major cardiac events occurred in 7.0% of men on testosterone gel and 7.3% on placebo.

Two things make that result especially relevant. The men studied were the ones most likely to have a heart event, and doses were adjusted to keep testosterone in the normal range, which is what a supervised plan aims for anyway. Neither condition applies to someone injecting large doses from an unlabeled vial.

The myth is wrong, but the worry behind it was not pointless. The same trial recorded more atrial fibrillation, acute kidney injury and pulmonary embolism with testosterone, and labels now carry blood pressure warnings. Our breakdown of the TRAVERSE trial lists each number and what it means for monitoring.

Myth 4: “TRT is just steroid abuse with paperwork”

The two share a molecule, not a goal. The Endocrine Society’s July 2026 statement says treatment at a dose similar to what a man would normally make has clear benefits for appropriately diagnosed hypogonadism, and that symptoms alone are not diagnostic. Abuse, as the Kyzatrex label describes it, means doses above those recommended, often stacked with other anabolic steroids.

Medical use still carries guardrails for a reason. Testosterone is a Schedule III controlled substance, and its label describes dependence behaviors such as taking more than recommended and struggling to stop. That is why a proper plan checks your levels instead of letting you chase a number. Our answers on whether TRT is the same as steroids and whether TRT is addictive go further.

Myth 5: “More testosterone means more fertility”

It usually works the other way. External testosterone signals the pituitary to cut back on FSH, and the Kyzatrex label warns that this can suppress sperm production, noting reduced fertility in some men on testosterone and that fertility effects may not always reverse. Men who want children soon need that conversation before the first dose, not after.

Options exist for men who want both hormone treatment and fertility. One is HCG (Pregnyl), which acts like the pituitary’s own signal to the testes and is sometimes added to a testosterone plan; our page on HCG with testosterone therapy explains when that makes sense. Our article on whether TRT affects fertility covers the wider picture, including how long recovery can take after stopping.

How Ultimate Male handles the real risks

Testing comes before any decision about testosterone therapy at our San Gabriel and Downey clinics. The TRT pre-screening panel checks total testosterone, estradiol, PSA and a complete blood count, and it is bundled with your first consultation with a PA-C or MD. Low numbers have to line up with symptoms that fit before treatment is discussed.

If you start, follow-up visits and labs are where the risks on this page get watched, and the plan changes when the numbers say it should. Bring the myth that worried you most to the free 10-minute call. It is a reasonable place to start a straight conversation.

questions

Common questions.

TRT Myths Men Still Believe, Checked Against the Evidence

Still unsure? Take the free assessment

Is testosterone a controlled substance?
Yes. Testosterone is a Schedule III controlled substance in the United States, which places it under tighter federal rules than most medicines and means it is dispensed only on a licensed clinician's order.
If TRT is safe for my heart, do I still need regular labs?
Yes. The same trial that eased the heart attack concern found more atrial fibrillation, blood clots and kidney injury, and testosterone raises red blood cell counts. Follow-up labs and blood pressure checks are how those risks get caught early.

This page is general education, not medical advice. A licensed clinician must review your symptoms, history and labs before any treatment decision. For chest pain, trouble breathing, signs of stroke or an erection lasting over four hours, call 911.

Ready when you are

Start with a free phone call.

Ten minutes. No pressure. We tell you honestly whether we can help.

Call 626-319-5261 Free assessment